44. 多発血管炎性肉芽腫症 Wegener granulomatosis Clinical trials / Disease details


臨床試験数 : 92 薬物数 : 106 - (DrugBank : 27) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 78

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01405807
(ClinicalTrials.gov)
February 201127/7/2011Alemtuzumab for ANCA Associated Refractory VasculitisAlemtuzumab for ANCA Associated Refractory Vasculitis - a Study of Safety and EfficacyVasculitis;Microscopic Polyangiitis;Granulomatosis With Polyangiitis;Wegener'sDrug: AlemtuzumabCambridge University Hospitals NHS Foundation TrustNULLRecruiting18 Years60 YearsBoth24Phase 4United Kingdom